BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38316960)

  • 1. Association of weight loss with cardiovascular or all-cause mortality in patients with heart failure: A meta-analysis.
    Wu X; Wang Y; Hu X
    Int J Obes (Lond); 2024 May; 48(5):626-634. PubMed ID: 38316960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis.
    Taylor RS; Walker S; Ciani O; Warren F; Smart NA; Piepoli M; Davos CH
    Health Technol Assess; 2019 May; 23(25):1-98. PubMed ID: 31140973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight loss increases all-cause mortality in overweight or obese patients with diabetes: A meta-analysis.
    Chen Y; Yang X; Wang J; Li Y; Ying D; Yuan H
    Medicine (Baltimore); 2018 Aug; 97(35):e12075. PubMed ID: 30170423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression after heart failure and risk of cardiovascular and all-cause mortality: a meta-analysis.
    Fan H; Yu W; Zhang Q; Cao H; Li J; Wang J; Shao Y; Hu X
    Prev Med; 2014 Jun; 63():36-42. PubMed ID: 24632228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex interaction of obesity, intentional weight loss and heart failure: a systematic review and meta-analysis.
    Mahajan R; Stokes M; Elliott A; Munawar DA; Khokhar KB; Thiyagarajah A; Hendriks J; Linz D; Gallagher C; Kaye D; Lau D; Sanders P
    Heart; 2020 Jan; 106(1):58-68. PubMed ID: 31530572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data.
    Pufulete M; Maishman R; Dabner L; Higgins JPT; Rogers CA; Dayer M; MacLeod J; Purdy S; Hollingworth W; Schou M; Anguita-Sanchez M; Karlström P; Shochat MK; McDonagh T; Nightingale AK; Reeves BC
    Syst Rev; 2018 Jul; 7(1):112. PubMed ID: 30064502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of magnitude of weight loss and weight variability with mortality and major cardiovascular events among individuals with type 2 diabetes mellitus: a systematic review and meta-analysis.
    Huang S; Shi K; Ren Y; Wang J; Yan WF; Qian WL; Yang ZG; Li Y
    Cardiovasc Diabetol; 2022 May; 21(1):78. PubMed ID: 35578337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observational Evidence for Unintentional Weight Loss in All-Cause Mortality and Major Cardiovascular Events: A Systematic Review and Meta-Analysis.
    De Stefani FDC; Pietraroia PS; Fernandes-Silva MM; Faria-Neto J; Baena CP
    Sci Rep; 2018 Oct; 8(1):15447. PubMed ID: 30337578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of weight loss in heart failure patients with overweight and obesity: a systematic review and meta-analysis.
    Chi M; Nie Y; Su Y; Wang N; Li A; Ma T; Hou Y
    Eur J Prev Cardiol; 2023 Nov; 30(17):1906-1921. PubMed ID: 37652032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial.
    ; Gregg EW; Jakicic JM; Blackburn G; Bloomquist P; Bray GA; Clark JM; Coday M; Curtis JM; Egan C; Evans M; Foreyt J; Foster G; Hazuda HP; Hill JO; Horton ES; Hubbard VS; Jeffery RW; Johnson KC; Kitabchi AE; Knowler WC; Kriska A; Lang W; Lewis CE; Montez MG; Nathan DM; Neiberg RH; Patricio J; Peters A; Pi-Sunyer X; Pownall H; Redmon B; Regensteiner J; Rejeski J; Ribisl PM; Safford M; Stewart K; Trence D; Wadden TA; Wing RR; Yanovski SZ
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):913-921. PubMed ID: 27595918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure.
    Sharma A; Lavie CJ; Borer JS; Vallakati A; Goel S; Lopez-Jimenez F; Arbab-Zadeh A; Mukherjee D; Lazar JM
    Am J Cardiol; 2015 May; 115(10):1428-34. PubMed ID: 25772740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight Loss in Obese Patients With Heart Failure.
    Zamora E; Díez-López C; Lupón J; de Antonio M; Domingo M; Santesmases J; Troya MI; Díez-Quevedo C; Altimir S; Bayes-Genis A
    J Am Heart Assoc; 2016 Mar; 5(3):e002468. PubMed ID: 27013541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology.
    Zafrir B; Salman N; Crespo-Leiro MG; Anker SD; Coats AJ; Ferrari R; Filippatos G; Maggioni AP; Mebazaa A; Piepoli MF; Ruschitzka F; Paniagua-Martin MJ; Segovia J; Laroche C; Amir O;
    Eur J Heart Fail; 2016 Jul; 18(7):859-68. PubMed ID: 27198159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart Rate Variability and Risk of All-Cause Death and Cardiovascular Events in Patients With Cardiovascular Disease: A Meta-Analysis of Cohort Studies.
    Fang SC; Wu YL; Tsai PS
    Biol Res Nurs; 2020 Jan; 22(1):45-56. PubMed ID: 31558032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for weight loss in people with chronic kidney disease who are overweight or obese.
    Conley MM; McFarlane CM; Johnson DW; Kelly JT; Campbell KL; MacLaughlin HL
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013119. PubMed ID: 33782940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis.
    Kanie T; Mizuno A; Takaoka Y; Suzuki T; Yoneoka D; Nishikawa Y; Tam WWS; Morze J; Rynkiewicz A; Xin Y; Wu O; Providencia R; Kwong JS
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013650. PubMed ID: 34693515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart Rate Variability and Prognosis in Hemodialysis Patients: A Meta-Analysis.
    Yang L; Zhao Y; Qiao B; Wang Y; Zhang L; Cui T; Fu P
    Blood Purif; 2021; 50(3):298-308. PubMed ID: 33291108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis.
    Ma C; Avenell A; Bolland M; Hudson J; Stewart F; Robertson C; Sharma P; Fraser C; MacLennan G
    BMJ; 2017 Nov; 359():j4849. PubMed ID: 29138133
    [No Abstract]   [Full Text] [Related]  

  • 20. Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.
    Kitson S; Ryan N; MacKintosh ML; Edmondson R; Duffy JM; Crosbie EJ
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012513. PubMed ID: 29388687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.